XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 32 $ 29,750,864 $ (28,673,992) $ 1,076,904
Beginning Balance, shares at Dec. 31, 2020 31,981,374      
Issuance of common stock for cash 50,000 50,000
Issuance of common stock for cash, shares 100,000      
Issuance of common stock for exercise of stock options 15,400 15,400
Issuance of common stock for exercise of stock options, shares 35,000      
Issuance of common stock for conversion of convertible debt $ 1 499,999 500,000
Issuance of common stock for conversion of convertible debt, shares 1,000,000      
Issuance of common stock for financing cost 1,440 1,440
Issuance of common stock for financing cost, shares 600      
Stock option expense 193,587 193,587
Net loss (4,417,663) (4,417,663)
Issuance of common stock for cashless exercise of stock options $ 1 (1)
Issuance of common stock for cashless exercise of stock options, shares 960,550      
Issuance of common stock for settlement of litigation 1,103,750 1,103,750
Issuance of common stock for settlement of litigation, shares 225,000      
Issuance of common stock for settlement agreement $ 1 3,240,599 3,240,600
Issuance of common stock for settlement agreement, shares 825,000      
Beneficial conversion feature associated with convertible debt 30,000 30,000
Ending balance, value at Mar. 31, 2021 $ 35 34,885,638 (33,091,655) 1,794,018
Ending Balance, shares at Mar. 31, 2021 35,127,524      
Beginning balance, value at Dec. 31, 2020 $ 32 29,750,864 (28,673,992) 1,076,904
Beginning Balance, shares at Dec. 31, 2020 31,981,374      
Net loss       (6,254,337)
Ending balance, value at Jun. 30, 2021 $ 35 36,817,909 (34,928,329) 1,889,615
Ending Balance, shares at Jun. 30, 2021 35,387,524      
Beginning balance, value at Mar. 31, 2021 $ 35 34,885,638 (33,091,655) 1,794,018
Beginning Balance, shares at Mar. 31, 2021 35,127,524      
Issuance of common stock for exercise of stock options   71,700   71,700
Issuance of common stock for exercise of stock options, shares 260,000      
Stock option expense   104,387   104,387
Net loss     (1,836,674) (1,836,674)
Fair value of warrants issued for financing costs   457,417   457,417
Beneficial conversion feature associated with convertible debt   810,634   810,634
Value of warrants issued with convertible debt   488,133   488,133
Ending balance, value at Jun. 30, 2021 $ 35 36,817,909 (34,928,329) 1,889,615
Ending Balance, shares at Jun. 30, 2021 35,387,524      
Beginning balance, value at Dec. 31, 2021 $ 36 39,275,591 (43,658,870) (4,383,243)
Beginning Balance, shares at Dec. 31, 2021 35,769,524      
Issuance of common stock for cash $ 28 13,700,000   13,700,028
Issuance of common stock for cash, shares 27,400,000      
Issuance of common stock for exercise of stock options $ 1 69,996   69,997
Issuance of common stock for exercise of stock options, shares 91,500      
Issuance of common stock for conversion of convertible debt $ 1 64,063   64,064
Issuance of common stock for conversion of convertible debt, shares 128,125      
Issuance of common stock for financing cost $ 1   1
Issuance of common stock for financing cost, shares 535,967      
Stock option expense   26,116   26,116
Net loss     (1,510,052) (1,510,052)
Ending balance, value at Mar. 31, 2022 $ 67 53,135,766 (45,168,922) 7,966,911
Ending Balance, shares at Mar. 31, 2022 65,725,116      
Beginning balance, value at Dec. 31, 2021 $ 36 39,275,591 (43,658,870) (4,383,243)
Beginning Balance, shares at Dec. 31, 2021 35,769,524      
Net loss       (2,707,243)
Ending balance, value at Jun. 30, 2022 $ 67 53,361,839 (46,366,113) 6,995,793
Ending Balance, shares at Jun. 30, 2022 65,921,991      
Beginning balance, value at Mar. 31, 2022 $ 67 53,135,766 (45,168,922) 7,966,911
Beginning Balance, shares at Mar. 31, 2022 65,725,116      
Issuance of common stock for cash      
Issuance of common stock for exercise of stock options   42,328   42,328
Issuance of common stock for exercise of stock options, shares 196,875      
Stock option expense   22,868   22,868
Net loss     (1,197,191) (1,197,191)
Fair value of warrants issued for financing costs   160,877   160,877
Ending balance, value at Jun. 30, 2022 $ 67 $ 53,361,839 $ (46,366,113) $ 6,995,793
Ending Balance, shares at Jun. 30, 2022 65,921,991